Overview

Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma

Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether everolimus is effective in the treatment of patients with advance cholangiocarcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Ratchavithi Hospital
Treatments:
Everolimus
Sirolimus